{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:49:16Z","timestamp":1758980956035},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2318,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2230.2008.03157.x","type":"journal-article","created":{"date-parts":[[2009,4,27]],"date-time":"2009-04-27T14:35:04Z","timestamp":1240842904000},"page":"491-492","source":"Crossref","is-referenced-by-count":4,"title":["Subacute cutaneous lupus erythematosus after immunotherapy for renal-cell carcinoma: the case for interferon-alpha"],"prefix":"10.1093","volume":"35","author":[{"given":"H. Y.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,4,27]]},"reference":[{"key":"10.1111\/j.1365-2230.2008.03157.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7326\/0003-4819-115-3-178","article-title":"Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors","volume":"115","author":"Ronnblom Le Alm","year":"1991","journal-title":"Ann Intern Med"},{"issue":"Suppl","key":"10.1111\/j.1365-2230.2008.03157.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1600-0560.2007.00715.x","article-title":"Lupus-lke reaction to interferon at the injection site: report of five cases","volume":"1","author":"Arrue","year":"2007","journal-title":"J Cutan Pathol"},{"key":"10.1111\/j.1365-2230.2008.03157.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1136\/ard.2004.033753","article-title":"Type 1 interferon correlates with serological and clinical manifestations of SLE","volume":"64","author":"Dall\ufffd\ufffd\ufffdera","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2230.2008.03157.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/art.21034","article-title":"Ultraviolet radiation-induced injury, chemokines and leukocyte recruitment: an ampliflication cycle triggering cutaneous lupus erythematosus","volume":"52","author":"Meller","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2230.2008.03157.x-BIB5|cit5","first-page":"251","article-title":"Type I interferons and systemic lupus erythematosus","volume":"7","author":"Koutouzov","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1111\/j.1365-2230.2008.03157.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.coi.2006.09.014","article-title":"Systemic lupus erythematosus: all roads lead to type I interferons","volume":"18","author":"Pascual","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"10.1111\/j.1365-2230.2008.03157.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2133.2007.08137.x","article-title":"The expression pattern of interferon - inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets","volume":"157","author":"Wenzel","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2008.03157.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","article-title":"The nature of the principal type I interferon-producing cells in human blood","volume":"284","author":"Siegel","year":"1999","journal-title":"Science"},{"key":"10.1111\/j.1365-2230.2008.03157.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/428480","article-title":"Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus","volume":"76","author":"Sigurdsson","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1365-2230.2008.03157.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/sj.gene.6364408","article-title":"High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus","volume":"8","author":"Niewold","year":"2007","journal-title":"Genes Immun"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2008.03157.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2230.2008.03157.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:28:11Z","timestamp":1676384891000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/35\/5\/491\/6622108"}},"subtitle":["SCLE after immunotherapy for RCC"],"short-title":[],"issued":{"date-parts":[[2009,4,27]]},"references-count":10,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2008.03157.x","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,27]]}}}